Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
Saved in:
| Title: | Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal. |
|---|---|
| Authors: | Venkatraman N; Jenner Institute, University of Oxford, United Kingdom., Ndiaye BP; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Bowyer G; Jenner Institute, University of Oxford, United Kingdom., Wade D; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Sridhar S; Jenner Institute, University of Oxford, United Kingdom., Wright D; Jenner Institute, University of Oxford, United Kingdom., Powlson J; Jenner Institute, University of Oxford, United Kingdom., Ndiaye I; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Dièye S; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Thompson C; Jenner Institute, University of Oxford, United Kingdom., Bakhoum M; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Morter R; Jenner Institute, University of Oxford, United Kingdom., Capone S; ReiThera Srl, Rome, Italy., Del Sorbo M; ReiThera Srl, Rome, Italy., Jamieson S; Jenner Institute, University of Oxford, United Kingdom., Rampling T; Jenner Institute, University of Oxford, United Kingdom., Datoo M; Jenner Institute, University of Oxford, United Kingdom., Roberts R; Jenner Institute, University of Oxford, United Kingdom., Poulton I; Jenner Institute, University of Oxford, United Kingdom., Griffiths O; Jenner Institute, University of Oxford, United Kingdom., Ballou WR; GlaxoSmithKline Biologicals, Rixensart, Belgium., Roman F; GlaxoSmithKline Biologicals, Rixensart, Belgium., Lewis DJM; National Institute for Health Research/Imperial Clinical Research Facility, Hammersmith Hospital, London, United Kingdom., Lawrie A; Jenner Institute, University of Oxford, United Kingdom., Imoukhuede E; Jenner Institute, University of Oxford, United Kingdom., Gilbert SC; Jenner Institute, University of Oxford, United Kingdom., Dieye TN; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Ewer KJ; Jenner Institute, University of Oxford, United Kingdom., Mboup S; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal., Hill AVS; Jenner Institute, University of Oxford, United Kingdom. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2019 Apr 08; Vol. 219 (8), pp. 1187-1197. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30407513 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Venkatraman+N%22">Venkatraman N</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ndiaye+BP%22">Ndiaye BP</searchLink>; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Bowyer+G%22">Bowyer G</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wade+D%22">Wade D</searchLink>; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Sridhar+S%22">Sridhar S</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wright+D%22">Wright D</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Powlson+J%22">Powlson J</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ndiaye+I%22">Ndiaye I</searchLink>; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Dièye+S%22">Dièye S</searchLink>; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Thompson+C%22">Thompson C</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bakhoum+M%22">Bakhoum M</searchLink>; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Morter+R%22">Morter R</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Capone+S%22">Capone S</searchLink>; ReiThera Srl, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Del+Sorbo+M%22">Del Sorbo M</searchLink>; ReiThera Srl, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Jamieson+S%22">Jamieson S</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rampling+T%22">Rampling T</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Datoo+M%22">Datoo M</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Roberts+R%22">Roberts R</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Poulton+I%22">Poulton I</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Griffiths+O%22">Griffiths O</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ballou+WR%22">Ballou WR</searchLink>; GlaxoSmithKline Biologicals, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Roman+F%22">Roman F</searchLink>; GlaxoSmithKline Biologicals, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Lewis+DJM%22">Lewis DJM</searchLink>; National Institute for Health Research/Imperial Clinical Research Facility, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lawrie+A%22">Lawrie A</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Imoukhuede+E%22">Imoukhuede E</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gilbert+SC%22">Gilbert SC</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dieye+TN%22">Dieye TN</searchLink>; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Ewer+KJ%22">Ewer KJ</searchLink>; Jenner Institute, University of Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mboup+S%22">Mboup S</searchLink>; Centre Hospitalier Universitaire le Dantec, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Hill+AVS%22">Hill AVS</searchLink>; Jenner Institute, University of Oxford, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2019 Apr 08; Vol. 219 (8), pp. 1187-1197. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30407513 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiy639 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1187 Titles: – TitleFull: Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Venkatraman N – PersonEntity: Name: NameFull: Ndiaye BP – PersonEntity: Name: NameFull: Bowyer G – PersonEntity: Name: NameFull: Wade D – PersonEntity: Name: NameFull: Sridhar S – PersonEntity: Name: NameFull: Wright D – PersonEntity: Name: NameFull: Powlson J – PersonEntity: Name: NameFull: Ndiaye I – PersonEntity: Name: NameFull: Dièye S – PersonEntity: Name: NameFull: Thompson C – PersonEntity: Name: NameFull: Bakhoum M – PersonEntity: Name: NameFull: Morter R – PersonEntity: Name: NameFull: Capone S – PersonEntity: Name: NameFull: Del Sorbo M – PersonEntity: Name: NameFull: Jamieson S – PersonEntity: Name: NameFull: Rampling T – PersonEntity: Name: NameFull: Datoo M – PersonEntity: Name: NameFull: Roberts R – PersonEntity: Name: NameFull: Poulton I – PersonEntity: Name: NameFull: Griffiths O – PersonEntity: Name: NameFull: Ballou WR – PersonEntity: Name: NameFull: Roman F – PersonEntity: Name: NameFull: Lewis DJM – PersonEntity: Name: NameFull: Lawrie A – PersonEntity: Name: NameFull: Imoukhuede E – PersonEntity: Name: NameFull: Gilbert SC – PersonEntity: Name: NameFull: Dieye TN – PersonEntity: Name: NameFull: Ewer KJ – PersonEntity: Name: NameFull: Mboup S – PersonEntity: Name: NameFull: Hill AVS IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 04 Text: 2019 Apr 08 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 219 – Type: issue Value: 8 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |